Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04831216 · ClinicalTrials.gov registry record · NA
Delivering Health: Addressing Diabetes and Food Insecurity
A NA study of Diabetes Mellitus, Type 2 and Food Insecurity, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
- 1
- Study location
NCT04831216: Completed NA study of Diabetes Mellitus, Type 2 and Food Insecurity, sponsored by University of Arkansas.
NCT04831216 is a NA study of Diabetes Mellitus, Type 2 and Food Insecurity that has completed, run by University of Arkansas. The registered enrollment target is 101 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04831216, a NA study of Diabetes Mellitus, Type 2 and Food Insecurity, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study was to develop, implement, and evaluate the effectiveness of an intervention to use home-delivery of Type 2 diabetes (T2D)-appropriate food boxes with plain language adapted education materials to improve the nutritional health, physical activity, and health outcomes of low-income food insecure people with T2D in northwest Arkansas.
Primary Outcome
A Siemens analyzer was utilized to measure HbA1c (%) via finger stick blood collection.
Conditions Studied
Interventions
- BEHAVIORAL Type 2 Diabetes Appropriate Food Boxes + Diabetes Education
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences Northwest - Fayetteville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2021-08-24 |
| Est. Completion | 2023-07-13 |
| Phase | NA |
What the finished NCT04831216 record still lists
NCT04831216 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Type 2 Diabetes Appropriate Food Boxes + Diabetes Education is the first listed.
NCT04831216 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT04831216 about?
NCT04831216 is a clinical study titled "Delivering Health: Addressing Diabetes and Food Insecurity". The goal of this study was to develop, implement, and evaluate the effectiveness of an intervention to use home-delivery of Type 2 diabetes (T2D)-appropriate food boxes with plain language adapted education materials to improve the nutritional health, physical activity, and health outcomes of low-in...
What is the current status of trial NCT04831216?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2021-08-24. Estimated completion is 2023-07-13.
What conditions does trial NCT04831216 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Food Insecurity.
What interventions are being tested in trial NCT04831216?
The interventions under investigation include: Type 2 Diabetes Appropriate Food Boxes + Diabetes Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT04831216?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04831216 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04831216's enrollment target sits among peer trials
101 200th of 348 higher than 149 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI